Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

被引:31
作者
Liu, Min [1 ,2 ]
Matsumura, Noriomi [1 ]
Mandai, Masaki [1 ]
Li, Kui [1 ]
Yagi, Haruhiko [1 ]
Baba, Tsukasa [1 ]
Suzuki, Ayako [1 ]
Hamanishi, Junzo [1 ]
Fukuhara, Ken [1 ]
Konishi, Ikuo [1 ]
机构
[1] Kyoto Univ, Dept Obstet & Gynecol, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China
关键词
ovarian; cancer; cyclooxygenase; clustering; CD8; CD57; CD1a; CD8(+) T-LYMPHOCYTES; NATURAL-KILLER-CELLS; HUMAN BREAST-CANCER; DENDRITIC CELLS; COLORECTAL-CANCER; CYCLOOXYGENASE-2; INHIBITORS; ENDOMETRIAL CARCINOMA; CERVICAL-CANCER; ASPIRIN USE; SURVIVAL;
D O I
10.1038/modpathol.2008.187
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Local immune status is influenced by the tumor microenvironment. This study aims to characterize the local immune/microenvironment status by examining tumor-infiltrating immune cells, as well as cyclooxygenase (COX) expression in tumor cells, and to analyze the relationship with the prognosis of ovarian cancers. Using immunohistochemical staining of 70 ovarian cancer specimens, the numbers of CD8+, CD57+, and CD1a+ cells infiltrating intraepithelial or stromal spaces were counted (six parameters). Hierarchical clustering was used to analyze the six parameters at one time. Expression of COX-1 and COX-2 in tumor cells was also analyzed by immunohistochemistry. Expression of both COX-1 and COX-2 was negatively correlated with intraepithelial CD8+ cells (P<0.05 for both). Hierarchical clustering using the six parameters classified ovarian cancers into three clusters. The overall and progression-free survival of cluster 1 with low CD8+ cell and high CD1a+ cell density was poorer than cluster 2 with high CD8+ cell density (P<0.05). The cluster classification did not correlate with clinical features, such as histology, stage, age, and amount of residual tumor. In a multivariate analysis, cluster 1 was an independent poor prognostic factor (P<0.05). Expression of both COX-1 and COX-2 was higher in cluster 1 than in cluster 2 (P<0.05, respectively). In conclusion, hierarchical clustering of tumor-infiltrating immune cells allows poor prognostic COX-high subgroup of ovarian cancer to be detected. COX may influence the pattern of tumor-infiltrating immune cells and prognosis in ovarian cancer.
引用
收藏
页码:373 / 384
页数:12
相关论文
共 57 条
[51]   Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis [J].
Stolina, M ;
Sharma, S ;
Lin, Y ;
Dohadwala, M ;
Gardner, B ;
Luo, J ;
Zhu, L ;
Kronenberg, M ;
Miller, PW ;
Portanova, J ;
Lee, JC ;
Dubinett, SM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :361-370
[52]   Cyclooxygenase-2 inhibitors in tumorigenesis (Part II) [J].
Taketo, MM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21) :1609-1620
[53]   Cyclooxygenase-2 inhibitors in tumorigenesis (Part I) [J].
Taketo, MM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (20) :1529-1536
[54]   Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib - Potential value as adjuvant therapy after surgery [J].
Tanaka, T ;
Delong, PA ;
Amin, K ;
Henry, A ;
Kruklitis, R ;
Kapoor, V ;
Kaiser, LR ;
Albelda, SM .
ANNALS OF SURGERY, 2005, 241 (01) :168-178
[55]   ASPIRIN USE AND REDUCED RISK OF FATAL COLON CANCER [J].
THUN, MJ ;
NAMBOODIRI, MM ;
HEATH, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1593-1596
[56]   Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma [J].
Tomsova, Marketa ;
Melichar, Bohuslav ;
Sedlakova, Iva ;
Steiner, Ivo .
GYNECOLOGIC ONCOLOGY, 2008, 108 (02) :415-420
[57]   Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor [J].
Yang, L ;
Yamagata, N ;
Yadav, R ;
Brandon, S ;
Courtney, RL ;
Morrow, JD ;
Shyr, Y ;
Boothby, M ;
Joyce, S ;
Carbone, DP ;
Breyer, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :727-735